Omics Solutions

Overview

High-throughput portfolio of multiple omics capabilities for holistic interrogation of the genome

Tempus offers a wide range of disease-agnostic technologies, including NGS, methylation testing, genotyping, proteomics, and single-cell sequencing, designed to support all phases from biomarker discovery to clinical development.

Customizable solutions across life sciences sectors for your program needs

Researchers
Enhance your research with integrated multi-omics data and insights.

Biopharma
Accelerate target discovery and development with precise biomarker identification.

Direct to consumer
Access high-quality genomics data and personalized health insights for your platform.

Learn more →

Tempus Ecosystem

Our research use only (RUO) omics testing solutions, alongside our vast data repository, biological modeling solutions, and sequencing tests, can offer comprehensive insights for disease mechanism analysis and translational research. Tempus supports clinical development from biomarker discovery to companion diagnostic development as an end-to-end provider.

Integrating multi-omics in R&D and clinical programs

Refine biomarker signatures and improve mechanisms of action (MOA) decisions with multiple omics datasets. Tempus offers the following testing capabilities with customizable workflows to meet your research goals.

Next-Generation Sequencing (NGS)

Tempus offers the full Illumina NGS suite of instruments, including NovaSeqX+
Whole Genome / Exome / Transcriptome Sequencing

Faster, powerful whole genome sequencing (30x-200x)
Low Pass WGS, with or without imputation, delivering large data quantities
Single-cell whole transcriptome sequencing with flexible coverage

Genotyping

Our wide portfolio of genotyping solutions fits the needs of small and high-volume projects:

Illumina

Medium-to-high throughput volumes
Multiple arrays for GWAS sample analysis
Custom array design available depending on project needs
Arrays and boosters for a wide variety of testing such as GSA, GDA, PGx booster and Neuro booster

Thermofisher

Medium-to-high throughput volumes
Enables GWAS, PGx, and Gene Expression analysis
Multiple sample formats

Methylation

As one of the highest-volume methylation testing laboratories in the country, we have robust methylation solutions with an optimized workflow for high-quality data

Extensive experience running Illumina Infinium EPIC 935k Bead Chip at a cost-effective price
Assay can provide data for research applications such as methylation profiling and biological age calculations
Supports data generation for EWAS analysis

Proteomics

Explore the proteome with our Olink and SomaLogic platforms*, designed for advanced biomarker discovery and multi-omic analysis. These technologies excel in measuring protein concentrations across various sample types, including plasma, serum, and more.

Olink Explore (Olink Explore 3072 and Olink Explore HT)

Measure ~2,400 protein targets with Olink Explore 3072
Quantify ~5,400 protein targets with Olink Explore HT
Access eight target 384-plex panels for disease-specific and biological process research**

SomaLogic SomaScan

Assess ~6,000 protein targets with SomaLogic SomaScan 7K
Measure ~11,000 protein targets with SomaLogic SomaScan 11K
SomaLogic SomaScan platforms provide a representation of 200+ biological pathways, including oncology, neurology, inflammation and cardiology

*Our proteomics technologies, including the advanced Olink and SomaLogic platforms, are designated for Research Use Only (RUO). They can be utilized for various research purposes, such as:

Retrospective analysis of clinical samples from an existing or previously closed clinical study and/or
Exploratory endpoint analysis within an existing clinical study or a clinical study still to be opened.

**Tailor your research with our customizable options; choose from eight specific 384-plex panels within the Explore 3072 library to focus on particular diseases and biological processes.

Single-cell RNA sequencing

Tempus offers the Parse Evercode WT and 10x Genomics Chromium X technologies for single-cell RNA sequencing

Gain a high-resolution view of cellular diversity, uncover rare cell populations and reveal gene expression of individual cells to assess heterogeneity
Experience end-to-end capabilities from sample processing, library preparation, and sequencing to bioinformatic analysis at competitive pricing
Our Parse Evercode WT offerings include the WT Mini (up to 10K cells, 1-12 samples), WT (10K-100K cells, 1-48 samples), WT Mega (100K-1M cells, 1-384 samples) and WT Penta (1M-5M cells, 1-384 samples) products
Our 10x Genomics Chromium X offerings include the Universal 5’ Gene Expression with optional TCR / BCR readouts, RNA Flex Gene Expression and Multiome (ATACseq + GEX) products

Spatial transcriptomics

Tempus offers the 10x Visium platforms for spatial transcriptomics

Map the gene expression of cells in their native tissue environment to reveal how physical location organizes and influences cellular identity and function.
This approach helps characterize relationships between molecular profiles and therapeutic response, create brain atlases, study developmental biology, and map immune responses.
Utilize the 10x Visium V2 at 25K read pairs per tissue-covered spot or Visium HD for 275M read pairs for fully captured area

Benefits of Tempus’ Omics Solutions

Streamlined vendor management
With solutions throughout the clinical development and research process, Tempus can be your sole vendor.

Complete solutions
From sample extraction to data delivery, we accommodate various sample types and project needs.

High-quality data
Trusted by over 200+ biopharma and over 50% of oncologists in the US, Tempus delivers robust data insights.

White glove project management
Receive real-time project updates from a dedicated project manager throughout the project’s duration.

Personalized services
Customizable and off-the-shelf assays tailored to your specific needs.

Expert support
Ph.D.-level analytical support for research and translational questions.

Automated workflows
Increased scalability and improved reproducibility.

Fast turnaround
Benefit from quick processing times and constant communication for project updates.

US-based operations
Reliable and efficient service with US-based state-of-the-art labs, processing, and customer support.

Our impact

It is great to have a familiar genomic service provider in Atlanta. [Tempus’ omics solutions] bring a lot of experience and has provided responsive and cost-effective methylation and gene expression profiling for us on multiple occasions.

—Dr. Greg Gibson, Professor and Director, Center for Integrative Genomics, Georgia Institute of Technology

The UC Athena project is utilizing [Tempus’ omics solutions] expert capabilities to screen for genome variants in the context of cancer.

—Dr. Laura van’t Veer, Professor and Endowed Chair in Cancer Research, Department of Laboratory Medicine, UCSF

We were attracted to [Tempus’ omics solutions] because of their outstanding quality and service-oriented approach as well as their know-how in molecular genetic technologies. The unique partnership with [Tempus’ omics solutions] will allow us to expand our comprehensive suite of services that have successfully supported the pharma market for nine years. Through this collaboration, we will be able to better serve all of our customers in the US, with the unmatched quality and value-added services that we have established over the past nine years.

—Dr. Thomas Henkel, CEO of Targos

We are very pleased to be working with [Tempus’ omics solutions]. They are a leading provider of genetic technologies, with advanced capabilities, including next-generation forensic profiling solutions, and most importantly excellent service This combination is critical to advancing the future of forensic investigation. We have already achieved success in several of recent projects that we have completed together.

—Dr. Laurence Rubin, CEO of Identitas

[Tempus’ omics solutions] is a leader in molecular genetic technologies, and is particularly known for its outstanding delivery of service.

—Don Rule, CEO of Translational Software

The information on this page is intended for life sciences companies and focuses on research and development applications.

This is AI-enabled precision medicine

This is the future of healthcare.